Generics News
India has become the largest supplier of drugs to the Russian market, overtaking Germany, which had been in the lead for the last two years, reports The Pharma Letter’s Russia correspondent. 4 June 2024
UK-based Alliance Pharma (AIM: APH) has successfully appealed against a Competition and Markets Authority (CMA) ruling that had found the company guilty of breaching competition law. 24 May 2024
On Thursday, the US Food and Drug Administration’s (FDA0 Center for Drug Evaluation and Research published its fiscal year 2023 (FY23) Generic Drug User Fee Amendments (GDUFA) Science and Research Report. 24 May 2024
Exclusive
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.
Most Read
In Brief
The US affiliate of Teva Pharmaceutical Industries announced today the launch of an authorized generic of Victoza (liraglutide injection 1.8mg), in the USA. 24 June 2024
Mergers and Acquisitions
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid on the part of Sun Pharmaceutical. 24 April 2024
5 April 2024
25 March 2024
11 March 2024
1 February 2024
19 January 2024
17 January 2024
Editor's Pick
Boardroom
Teva lures former Merck SVP to its executive team 15 May 2024
Israeli generics giant Teva Pharmaceutical Industries (TLV: TEVA) has reported its latest quarterly financial results against a backdrop of war in its home regi 8 November 2023
Executive management change at Teva 29 September 2023
STADA appoints Christos Gallis as head of Eastern Europe 15 June 2023